By using appropriate amounts of four bacteriophage 429 DNA replication proteins-terminal protein, DNA polymerase, protein p6 (double-stranded DNA-binding protein), and protein p5 (single-stranded DNA-binding protein)-it has been possible to amplify limited amounts of the 19,285-bp-long 429 DNA molecule by three orders of magnitude after 1 hr of incubation at 300C. Moreover, the quality of the amplified material was demonstrated by transfection experiments, in which infectivity of the synthetic (amplified) 429 DNA, measured as the ability to produce phage particles, was identical to that of the natural 429 DNA obtained from virions. The results presented in this paper establish some of the requisites for the development ofisothermal DNA amplification strategies based on the bacteriophage 429 DNA replication machinery that are suitable for the amplification of very large (>70 kb) segments of DNA.
The genome ofBacillus subtilis phage 429 consists of a linear double-stranded DNA (19,285 bp) , with a 6-bp-long inverted terminal repeat and a terminal protein (TP) covalently linked at both 5' ends (reviewed in ref. 1) . Since the first proposal by Rekosh et al. (2) , by which a free molecule of TP would act as a primer to initiate synthesis at both ends of the linear DNA molecule, the availability ofin vitro replication systems for both adenovirus and bacteriophage 429 allowed the confirmation of this hypothesis and the characterization of the functional role of other replication proteins involved in this process (reviewed in ref. 1) .
As depicted in Fig. 1 , initiation of 429 DNA replication is triggered by the viral protein p6 (double-stranded DNAbinding protein; DBP), which forms a nucleoprotein complex at both 429 DNA ends, producing a conformational change in the DNA that probably leads to local opening of the DNA duplex (5) . The primer TP forms a 1:1 complex with 429 DNA polymerase that recognizes both ends of the linear 429 DNA molecule (replication origins). Then, in the presence of dATP and Mg2+, 429 DNA polymerase catalyzes the formation of a covalent bond between dAMP and the OH group of Ser-232 of the TP acting as primer (6, 7) . In this reaction, dATP is selected by base complementarity with the second 3'-nucleotide of the template strand (8) . After this initiation step, dissociation of the TP-DNA polymerase heterodimer is likely to occur (transition) to replace the TP-DNA polymerase interactions required for initiation by the DNA polymerase-DNA interactions required for the elongation of the newly created DNA primer. Concomitantly, an asymmetric translocation (sliding back) of only TP-dAMP, but not of the template, followed by addition of a new dAMP residue, allows the recovery of the information corresponding to the first template nucleotide (8) . During elongation, 429 DNA polymerase catalyzes highly processive polymerization coupled to strand displacement (9) , and, therefore, complete replication of both strands proceeds continuously from each terminal priming event. As the two replication forks move, DNA synthesis is initially coupled to strand displacement of long stretches of single-stranded 429 DNA, producing type I replicative intermediates (see Fig. 1 ). When the two replication forks, moving in opposite directions, merge, a new type of replicative intermediate (type II) is formed. Electron microscopy analysis of 429 replicative intermediates in vitro showed that the viral protein p5 binds to the single-stranded portion of both type I and II molecules, thus acting as a single-stranded DNA-binding protein (SSB) during )29 DNA replication (4) . Once polymerization of both strands has been completed, the two DNA polymerase molecules dissociate from the DNA to reassume initiation and replication of a new 429 DNA molecule.
The symmetrical mode of 429 DNA replication is similar in several aspects (primed initiation at the ends of a linear DNA molecule and continuous synthesis of both strands) to the most widely used DNA amplification technique: PCR. However, the natural 429 DNA amplification system has significant differences derived from the nature of the primers (TP), from the fact that both DNA ends are true replication origins and, therefore, no thermal denaturation is required to position primers; and from the specific strand displacement coupled to DNA synthesis catalyzed by 429 DNA polymerase, which allows this enzyme to replicate extremely long double-stranded DNA molecules in isothermal conditions. In this paper, as the initial step in the development of amplification vectors based on the 429 DNA replication machinery, we have characterized the minimal protein factors required in vitro for the efficient TP-primed amplification of limited amounts of 429 DNA.
MATERIALS AND METHODS
Nucleotides, Proteins, and DNA Templates. Unlabeled dNTPs and [a-32P]dNTPs (410 Ci/mmol; 1 Ci = 37 GBq) were obtained from Amersham. 429 DNA polymerase (Mr = 66,520) and TP (Mr = 30,918) were overproduced in Escherichia coli cells and purified essentially as described (10, 11) . Protein p6 (Mr = 11,873) and protein p5 (Mr = 13,212), obtained from 429-infected B. subtilis cells, were purified as described (12, 13) . TP-linked DNA from 429 susl4 (1242) virions, isolated as described (14) , was used as input template for in vitro amplification experiments and as a control DNA in transfection experiments.
Phage and Bacterial Strains. Bacteriophage 429 susl4 (1242) has a nonsense (sus) mutation in gene 14 (15) , which produces a delayed lysis phenotype when plated in the nonpermissive strain B. subtilis 11ONA Try-spoA (16 Infectivi Assay for the in Vitro-Ampf ed 4¢9 DNA. In this case, the in vitro amplification conditions were as described above except that the input 429 DNA (0.5 ng) was incubated with TP-DNA polymerase complex (15 ng), free TP (20 ng), DBP (10 pg), and SSB (8 jig), in the presence of the four unlabeled dNTPs each at 80 AM. After 2 hr at 30"C, the reaction was stopped with 10 mM EDTA, and the DNA was precipitated with ethanol and resuspended in 10 mM Tris-HCl (pH 7.5)/0.1 mM EDTA. As an in vivo control of infectivity, 500 ng of the 429 DNA used as input for amplification was incubated under exactly the same conditions but in the absence of dNTPs. After 2 hr at 300C, the control 429 DNA was processed as described for the in vitro-amplified 4)29 DNA. Aliquots of the amplified 429 DNA were quantitated by alkaline agarose gel electrophoresis (20) and ethidium bromide staining. Different amounts of 429 DNA (control or amplified) were used to transfect B. subtilis BG295 (suppressor strain)-competent cells, prepared as described (21) . After transfection, infectivity, expressed as plaque-forming units (pfu), was determined by plating on B. subtilis Su+44 suppressor strain.
RESULTS
Requirements for in Vitro Amplfation of 029 DNA. It was reported that the complete replication of both 029 DNA strands in vitro required only two proteins: the 429 TP, which acts as initiation primer, and the viral DNA polymerase (22) . However, this minimal system was defined using a considerable amount of 429 DNA template (0.5 Mg; 1.6 nM), and, therefore, we reconsidered the characterization of the proteins required for an efficient DNA amplification in vitro (i.e., starting from limited amounts of 429 DNA). Fig. 2A shows that the amount of DNA synthesized when using a minimal system formed by TP and DNA polymerase is strongly dependent on the amount of input 429 DNA. Thus, in vitro synthesis occurred at input doses of 500 ng (4 nM) and 50 ng (0.4 nM), but it was almost undetectable at A DNApoI+TP+p5(SSB) input doses corresponding to 0.5 ng (4 pM) and 5 ng (0.04 nM); no reaction was observed even after overnight incubation. Therefore, initiation is probably the rate-limiting step: it is very inefficient at low ratios between DNA replication origins and the minimal initiation proteins (TP-DNA polymerase complex). As expected from previous data (23), addition of DBP to the in vitro minimal system produced only a 1.5-to 2-fold increase in the amount of DNA synthesized at any of the input )29 DNA doses tested. Also in agreement with previous reports (24) , addition of SSB to the minimal system produced a stimulation of about 4to 5-fold in the amount of synthesized DNA when starting with either 500 ng or 50 ng of input )29 DNA; however, at the lower doses of input DNA tested, the effect of adding SSB was negligible. On the other hand, the simultaneous addition of viral DBP and SSB to the minimal system resulted in a high yield of in vitro-synthesized DNA, even when starting with either 5 ng or 0.5 ng of input DNA template. Analysis of the titration curves shown in Fig. 3 indicates that both DBP and SSB are required in high amounts to obtain an efficient amplification.
Thus, in the presence of the four viral proteins, it was possible to amplify by three orders of magnitude the amount of input 429 DNA (see Fig. 2B ). Under these conditions, an exponential increase of in vitro-synthesized DNA could be obtained as a function of the time of incubation (data not shown), indicating not only a high efficiency in terms of number of initiation events but also the occurrence of full elongation of both DNA strands.
Size Analysis of the in Vitro-Ampliflied 029 DNA. Fig. 4   (lanes 1-4) shows the size analysis of the amplified 4)29 DNA obtained in vitro in an experiment similar to that shown in Fig. 2 , using each of the four combinations of viral proteins and starting with 0.5 ng of input 429 DNA. Interestingly, the amplified DNA, obtained only in the presence of the four viral proteins (Fig. 4, lane 4) , corresponded to full-length 429 DNA. Moreover, electron microscopy analysis of the DNA amplified under these conditions indicated the accumulation of mature 429 DNA molecules (data not shown). The amplification factor obtained (1460-fold) implies a maximal time of about 6 min per duplication cycle; the amount of 429 DNA synthesized under these conditions (730 ng/58 fmol) is close to the limit imposed by the amount of dNTPs provided.
A delicate equilibrium (stoichiometry) of initiation and elongation factors required for the efficient in vitro amplification of 429 DNA can be clearly observed in Fig. 4 , lanes [5] [6] [7] [8] [9] . At a fixed concentration of DBP and SSB, a small increase in the amount ofTP-DNA polymerase complex with respect to the one allowing optimal amplification of fulllength 429 DNA leads to the generation of immature elongation products, although the amount of DNA synthesized was roughly similar. This result is interpreted as the consequence of an imbalance between the number of initiations (increased) and the ratio of elongation factors to growing (DBP), and p5 (SSB)] were added as indicated. After 1 hr of incubation at 300C, the reaction was stopped with 10 mM EDTA, the amount of synthesized DNA was quantitated as described, and the size of the amplified DNA was analyzed by alkaline agarose gel electrophoresis followed by autoradiography (A) and ethidium bromide staining (B). The amplification factor corresponding to each particular condition, calculated as described in the legend to Fig. 2 , is indicated. The arrows at the left indicate the electrophoretic mobility of full-length 429 DNA obtained from virions. DNA chains (reduced). Moreover, the size ofthe synthesized DNA was linearly dependent on the amount of SSB (data not shown). On the other hand, in the absence of SSB, and using a large amount (60 ng) of TP-DNA polymerase complex, it was possible to observe a large stimulation in the amount of short elongation products as a consequence of adding DBP (Fig. 4, lanes 10 and 11) . This result allows us to conclude that binding ofDBP to the 4)29 DNA replication origins is the main factor stimulating the initiation stage in these in vitro amplification conditions. Therefore, it is tempting to speculate that, in addition to facilitating the opening of 429 DNA replication origins, DBP increases the affinity of the TP-DNA polymerase complex by the 429 DNA ends. On the other hand, SSB, in addition to preventing the nonproductive binding of replication proteins to the displaced strands (25), appears to be critical for the progression (maturation) of the multiple replication forks initiated at both 4)29 DNA replication origins.
All these results agree with the importance of the four viral proteins for 429 DNA replication in vivo (26, 27) and also emphasize the necessity of a precise stoichiometry of these proteins to maintain the equilibrium between the initiation and elongation stages of replication.
Infectivity of the in Vitro-Amplified 429 DNA. As a quality control of the in vitro amplification procedure described in this paper, the infectivity of the synthetic (in vitro) 429 DNA, DNA was virtually identical; the transfection efficiency was '104 pfu/pg. Moreover, the size distribution of individual plaques was also identical, indicating the absence of in vitro mutations affecting phage growth. These results indicate that the in vitro 429 DNA amplification system produces mature molecules and also suggest that DNA synthesis is being carried out with high fidelity. This could be expected if one takes into account previous estimations of the insertion fidelity of 4)29 DNA polymerase (28) and its strong 3' -* 5' exonuclease activity (29, 30) . A minimal estimate of the fidelity ofthis amplification system is the fact that no plaques were obtained when the transfection mixture corresponding to the in vitro-amplified 429 DNA was plated in nonpermissive B. subtilis cells. This was the expected result if the nonsense mutation present in the input 429 DNA was maintained in the in vitro-amplified 429 DNA molecules.
DISCUSSION
In this paper, one of the most efficient in vitro DNA replication systems described so far is presented. By using four 429 DNA replication proteins-TP (primer), DNA polymerase, protein p6 (DBP), and protein p5 (SSB)-it has been possible to amplify the 19,285-bp-long 429 DNA molecule by three orders of magnitude after 1 hr of incubation at 300C. As it occurs during 4)29 DNA replication in vivo, each of these proteins was an absolute requirement. The biological activity of the in vitro-amplified 429 DNA was demonstrated by its ability to produce phage 429 particles when transfected into B. subtilis cells. It was expected that, under the different conditions used, the amount of DNA synthesized (amplified) would largely depend on the efficiency of initiation and the frequency of reinitiations both on the same and/or different DNA molecules. Moreover, elongation was not expected to be rate-Biochemistry: Blanco et Proc. Natl. Acad. Sci. USA 91 (1994) limiting because once a molecule is initiated, complete elongation could be achieved in about 5 min (9) . However, size analysis of the synthesized DNA indicates that at a high ratio among initiation factors (TP, DNA polymerase, and DBP) and input DNA (replication origins), there is a blockage of elongation that can be only prevented by addition of the SSB protein. This blockage could be due to a "mechanical" hindrance produced by the multiple displaced strands originated from frequent reinitiations at the same origin.
A variety of nucleic acid amplification techniques, developed as tools for nucleic acid analysis and manipulation, are also being successfully applied for clinical diagnosis of genetic and infectious diseases. Amplification techniques (reviewed in ref. 31 ) can be grouped into (i) those requiring temperature cycling (PCR and ligase chain reaction) and (ii) isothermal systems [transcription-based amplification systems (3SR and NASBA), strand-displacement amplification, and QP replication systems]. Two aspects are frequent caveats in these procedures: fidelity of synthesis and length of the amplified product. As it has been recently reported, the use of proofreading polymerases (containing 3' --5' exonuclease activity) in combination with 3' --5' exo-deficient enzymes significantly increases not only fidelity but also the size limit of the amplification reaction (32, 33) .
The results presented in this paper establish basic requirements for the development of an amplification system relying on the mechanism of phage 429 DNA replication. This system would be adequate for faithful amplification of DNA molecules longer than 70 kb (9), largely over the size limit obtained with the amplification systems available to date. This procedure of isothermal TP-primed amplification would exploit the peculiar properties of 429 DNA polymerase: (i) ability to use a protein as primer, (ii) intrinsic high processivity (>70 kb), and (iii) strand displacement coupled to DNA synthesis. This procedure would also require the action of the viral DBP, to efficiently recognize and activate the 429 DNA replication origins (which should be present at the ends of the target DNA to be amplified), and SSB, to allow maturation of replicative intermediates and reinitiation on new DNA molecules. The sequences at 429 DNA ends that are active as minimal replication origins (34) and the location of the protein p6 nucleation site absolutely required for protein p6 binding and activation of the 429 DNA replication origins (3) have been determined. Therefore, DNA molecules suitable for TP-primed amplification could be directly obtained by ligation of double-stranded DNA fragments containing the 429 DNA replication origins to both ends of the DNA molecule to be amplified. Alternatively, selective (targeted) amplification would require initial stages of single-stranded DNA priming based on the use of dual primers (specific sequence plus 429 DNA origin sequence) to obtain specific doublestranded DNA linear molecules flanked by 429 DNA replication origins. Once these molecules are formed and the 4)29 DNA replication proteins are provided, initiation, progression, and resolution steps would occur continuously, producing an amplification cascade similar to that occurring during viral infection. This work is dedicated to the memory of Severo Ochoa. We are grateful to Dr. C. Gutidrrez for the electron microscopy analysis of 429 DNA amplification products. We are also grateful to Dr. J. C.
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